Seroprevalence of tetanus antibodies among pregnant women in Duhok Governorate, Iraq.

Maternal immunization with tetanus toxoid (TT) is the most effective was to prevent neonatal tetanus. In Duhok, Iraq data indicate low vaccination coverage. This study assessed TT immunization status among 600 randomly selected pregnant women attending Azadi teaching hospital, Duhok for delivery, by both tetanus antibody seroprevalence and TT history. WHO criteria for protective levels were used for seroprevalence and vaccination history. Overall, 90% of the women at delivery had protective tetanus antitoxin titres compared to only 55% considered protected according to their vaccination history. Immunity rates for women who had received no TT vaccination, 1 dose, 2 doses and > or = 3 doses were 28.0%, 92.6%, 100.0% and 99.0% respectively. Groups with lower serological immunity levels were women aged less than 25 years, those reporting no history of vaccination and those living in Akre, Bardarash or Shekhan districts of Duhok. Tetanus immunity determined by seroprevalence of tetanus antitoxin levels exceeded that estimated by vaccination history, and serological markers should be used instead of vaccination history in determining immunity status.

[1]  S. Cousens,et al.  Tetanus toxoid immunization to reduce mortality from neonatal tetanus , 2010, International journal of epidemiology.

[2]  H. Kocamaz,et al.  Neonatal tetanus in Turkey; what has changed in the last decade? , 2008, BMC infectious diseases.

[3]  S. Erdoğan,et al.  Prevalence of tetanus immunity in the Kocaeli Region, Turkey. , 2005, Japanese journal of infectious diseases.

[4]  M. Wharton,et al.  Serologic Immunity to Diphtheria and Tetanus in the United States , 2002, Annals of Internal Medicine.

[5]  J. Dokmetjian,et al.  A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxin. , 2000, Vaccine.

[6]  Henry Nider,et al.  Report of the Committee on Infectious Diseases , 1989 .

[7]  E. Cooperman Report of the Committee on Infectious Diseases , 1978, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[8]  L. K. Wolf Teaching health statistics. , 1948, The American journal of nursing.

[9]  The immunological basis for immunization series Module , 2009 .

[10]  Z. Baykan,et al.  Tetanus immunization in pregnant women. Serum levels of antitetanus antibodies at time of delivery , 2004, European Journal of Epidemiology.

[11]  M. Deming,et al.  Tetanus toxoid coverage as an indicator of serological protection against neonatal tetanus. , 2002, Bulletin of the World Health Organization.

[12]  E. M. Redwan,et al.  Prevalence of tetanus immunity in the Egyptian population. , 2002, Human antibodies.

[13]  M. Birmingham,et al.  Protocol for assessing neonatal tetanus mortality in the community using a combination of cluster and lot quality assurance sampling. Field test version. , 2002 .

[14]  O. Simonsen,et al.  ELISA for the routine determination of antitoxic immunity to tetanus. , 1986, Journal of biological standardization.